| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036381811 |
| P356 | DOI | 10.1186/2044-5040-1-15 |
| P932 | PMC publication ID | 3156638 |
| P698 | PubMed publication ID | 21798095 |
| P5875 | ResearchGate publication ID | 51529528 |
| P50 | author | Silvère M van der Maarel | Q59661580 |
| Vered Raz | Q87734521 | ||
| John Vissing | Q90104169 | ||
| Baziel van Engelen | Q110544835 | ||
| Seyed Yahya Anvar | Q114417603 | ||
| Andrea Venema | Q117249159 | ||
| Barbara van der Sluijs | Q130279306 | ||
| Gert-Jan van Ommen | Q29643727 | ||
| Capucine Trollet | Q42323052 | ||
| Peter A.C. 't Hoen | Q57190543 | ||
| P2093 | author name string | Martine Simonelig | |
| Aymeric Chartier | |||
| George Dickson | |||
| Marc Snoeck | |||
| P2860 | cites work | Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling | Q21144354 |
| Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy | Q24308826 | ||
| Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes | Q24645701 | ||
| DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Nuclear inclusions in oculopharyngeal dystrophy | Q72843808 | ||
| Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids | Q79698970 | ||
| Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA | Q28139419 | ||
| Normalization of cDNA microarray data | Q28181692 | ||
| The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13 | Q28304113 | ||
| Repeatability of published microarray gene expression analyses | Q28307780 | ||
| Identification of ubiquitin ligases required for skeletal muscle atrophy | Q28582211 | ||
| Recognition and processing of ubiquitin-protein conjugates by the proteasome | Q29547616 | ||
| Gene expression profile of aging and its retardation by caloric restriction | Q29614554 | ||
| The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes | Q30306225 | ||
| Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres | Q34102486 | ||
| Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice | Q34415166 | ||
| A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. | Q34518248 | ||
| Signaling in muscle atrophy and hypertrophy | Q34593198 | ||
| Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy. | Q35079093 | ||
| The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. | Q35558459 | ||
| Proteasome and peptidase function in MHC-class-I-mediated antigen presentation | Q35634031 | ||
| The role of ubiquitin-proteasome-dependent proteolysis in the remodelling of skeletal muscle. | Q35856003 | ||
| Ubiquitin-protein ligases in muscle wasting | Q36241893 | ||
| Anni 2.0: a multipurpose text-mining tool for the life sciences | Q36787149 | ||
| Skeletal muscle proteolysis in aging. | Q37341420 | ||
| Targeting the ubiquitin system in cancer therapy | Q37424802 | ||
| Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy | Q38318433 | ||
| A global test for groups of genes: testing association with a clinical outcome | Q38522319 | ||
| In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. | Q40438611 | ||
| PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions. | Q40449021 | ||
| Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy | Q44565973 | ||
| Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol | Q44569024 | ||
| Altered proteasome structure, function, and oxidation in aged muscle | Q45242260 | ||
| Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. | Q46656918 | ||
| Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes | Q47862955 | ||
| Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells. | Q50714075 | ||
| Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. | Q51788354 | ||
| Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy. | Q52097209 | ||
| Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin–proteasome pathway | Q57673583 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| limma | Q112236343 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| ubiquitin-proteasome system | Q47175589 | ||
| P304 | page(s) | 15 | |
| P577 | publication date | 2011-04-04 | |
| P1433 | published in | Skeletal Muscle | Q27723741 |
| P1476 | title | Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients | |
| P478 | volume | 1 |
| Q37610585 | "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders |
| Q37298886 | A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging |
| Q40629006 | Cytokine genes as potential biomarkers for muscle weakness in OPMD. |
| Q64236077 | Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting |
| Q42907623 | Dysfunctional transcripts are formed by alternative polyadenylation in OPMD. |
| Q91843569 | Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD) |
| Q34071347 | Interspecies translation of disease networks increases robustness and predictive accuracy. |
| Q37625578 | Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age. |
| Q35093811 | Major aging-associated RNA expressions change at two distinct age-positions. |
| Q35224241 | Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis |
| Q38575523 | Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein |
| Q61448849 | Normal Ribosomal Biogenesis but Shortened Protein Synthetic Response to Acute Eccentric Resistance Exercise in Old Skeletal Muscle |
| Q50962265 | Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology. |
| Q34788237 | Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy |
| Q37507541 | Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing |
| Q34449597 | Oculopharyngeal muscular dystrophy as a paradigm for muscle aging |
| Q36010483 | PABPN1-Dependent mRNA Processing Induces Muscle Wasting. |
| Q38100286 | PABPN1: molecular function and muscle disease |
| Q36305636 | Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation |
| Q35789502 | RNA-binding protein misregulation in microsatellite expansion disorders |
| Q35790486 | The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein |
Search more.